BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090

  October 5, 2007

   · 

  4 min read
• Policy

  Medtronic, Inc. to Present Findings from the Comprehensive ENDEAVOR Clinical Experience to FDA Advisory Panel

  October 5, 2007

   · 

  1 min read
• FDA

  Shire Pharmaceuticals Group plc’s ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome

  October 5, 2007

   · 

  5 min read
• Deals

  Bayer HealthCare Cleared to Acquire Citracal(R) Addition of Leading Calcium Brand Enriches Consumer Care Division’s Key Nutritionals Product Portfolio

  October 5, 2007

   · 

  3 min read
• FDA

  Genzyme Corporation Receives Approval to Market Elaprase(R) in Japan

  October 5, 2007

   · 

  5 min read
• Business

  Symmetry Medical Inc. Says UK Unit Overstated Revenue

  October 5, 2007

   · 

  1 min read
• Pharm Country

  Horizon Therapeutics Scheduled to Present at Upcoming BioPartnering Europe Meeting

  October 5, 2007

   · 

  1 min read
• Policy

  Pozen, Inc. Plans to Submit Response to Approvable Letter For Trexima(TM) Within the Next Ten Days

  October 5, 2007

   · 

  1 min read
• Biotech Bay

  PointCross Releases Pre-Clinical Study Lifecycle and Data Management Suite

  October 5, 2007

   · 

  2 min read
• FDA

  Novartis International AG Says Osteoporosis Drug Approved in Europe

  October 5, 2007

   · 

  1 min read